Answers are grounded in this paper and cite their sources.
Thirty-three percent of LTx recipients developed VTE, 71% within the first 6 months after LTx. Seventy percent of cases were acute PE, but fatal or severe nonfatal PE were rare. No effect of VTE on graft survival was seen; CLAD-free survival was shorter in patients with late VTE compared to patients without VTE.
No takes yet. Share an insight, caveat, or question.
Ruigrok et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: